A patent fight has already delayed Sandoz' biosimilar version of Amgen's anti-inflammatory blockbuster Enbrel. And now, it looks as if Sandoz will have to wait a little longer for a clear shot at the ...
Novartis’ Sandoz is looking to biosimilars to help it out of an industry-wide generics slump. And to spur greater uptake of those drugs, it has new data supporting switching patients from branded ...
More Golf: Leaderboard | Rankings | Schedule | Expert Picks | Equipment | FedEx Cup First, you should know this is not a jab at arthritis or anyone who suffers from it. I have multiple family members ...
Enbrel and Humira are biologic drugs that inhibit tumor necrosis factor (TNF)-alpha, reducing inflammation and joint damage associated with RA. Enbrel and Humira have many similarities, including how ...
Samsung Bioepis is months away from winning European clearance to market a copy of Amgen ($AMGN) and Pfizer's ($PFE) blockbuster rheumatoid arthritis treatment Enbrel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback